NVDA 
TSLA 
MSTR 
AAPL 
PLTR 
AMD 
INTC TLDR RNAZ jumps as TransCode files IND amendment for Phase 2a colorectal trial TransCode expands PRE-I-SPY into colorectal cancer with TTX-MC138 study RNAZ holds gains as Phase 2a trial targets ctDNA-positive MRD patients IND amendment clears path for TTX-MC138 dose-expansion trial in 2026 TransCode sets…
TLDR MSFT slides after downgrade flags rising costs and margin pressure risk Azure slowdown raises concern as competition strengthens Stifel…
TLDR Nuburu stock dips as defense pivot and capital restructuring accelerate Nuburu pushes defense expansion while shares hover near session…
TLDR Opus 4.6 boosts reasoning, coding depth, and stability across technical tasks. New 1M-token context window cuts drift and strengthens…
TLDR AIM stock spikes as pancreatic cancer trial reports survival gains AIM rallies on Phase 2 data showing extended cancer…
Stocks & Shares News
View MoreTLDR RNAZ jumps as TransCode files IND amendment for Phase 2a colorectal trial TransCode expands PRE-I-SPY into colorectal cancer with TTX-MC138 study RNAZ holds…
TLDR MSFT slides after downgrade flags rising costs and margin pressure risk…
TLDR Nuburu stock dips as defense pivot and capital restructuring accelerate Nuburu…
TLDR AIM stock spikes as pancreatic cancer trial reports survival gains AIM…
AI News
View MoreTLDR Opus 4.6 boosts reasoning, coding depth, and stability across technical tasks. New 1M-token context window cuts drift and strengthens…
Tech News
View MoreTLDR Anthropic launched Claude Opus 4.6, an AI model with improved coding skills and financial analysis capabilities FactSet Research Systems stock dropped 9.1% following the announcement…
